No title
Size Exclusion Chromatography (SEC) is a crucial analytical tool employed by Novo Nordisk for the assessment of potential aggregation in active pharmaceutical ingredients (API) derived from peptides and protein biopharmaceuticals. This investigation focuses on SEC analyses conducted under denaturing conditions, utilizing Ultra High-Performance Liquid Chromatography (HULK) adapted columns. Intrigui
